Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
advisory, affiliate, Antitrust, committee, confirm, EMEA, fifteen, HSR, inMedImmune, Ireland, irrevocable, jurisdiction, muscle, myofascial, orthopedic, parallel, perpetual, point, predefined, PTI, satisfaction, spread, tension
Removed:
eventually, IND, ofMedImmune, QLT, understand
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.51 Amendment No. 1 to License Agreement - Epicept Corporation
- 10.52 Development and License Agreement - Alpharma Ireland Limited
- 31.1 Rule 13A-14(A) Section 302 Certification of James E. Brown
- 31.2 Rule 13A-14(A) Section 302 Certification of Matthew J. Hogan
- 32.1 Certificate Pursuant to 18 U.s.c. Section 1350 of James E. Brown
- 32.2 Certificate Pursuant to 18 U.s.c. Section 1350 of Matthew J. Hogan
Related press release
DRRX similar filings
Filing view
External links